These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

953 related articles for article (PubMed ID: 8906828)

  • 1. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
    Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
    Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
    Ramachandra L; Kovats S; Eastman S; Rudensky AY
    J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tetraspanin protein CD82 associates with both free HLA class I heavy chain and heterodimeric beta 2-microglobulin complexes.
    Lagaudrière-Gesbert C; Lebel-Binay S; Wiertz E; Ploegh HL; Fradelizi D; Conjeaud H
    J Immunol; 1997 Mar; 158(6):2790-7. PubMed ID: 9058814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain.
    Busch R; Vturina IY; Drexler J; Momburg F; Hämmerling GJ
    Eur J Immunol; 1995 Jan; 25(1):48-53. PubMed ID: 7843252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Class I HLA folding and antigen presentation in beta 2-microglobulin-defective Daudi cells.
    Martayan A; Sibilio L; Tremante E; Lo Monaco E; Mulder A; Fruci D; Cova A; Rivoltini L; Giacomini P
    J Immunol; 2009 Mar; 182(6):3609-17. PubMed ID: 19265139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing HLA-B7 conformational shifts induced by peptide-binding groove mutations and bound peptide with anti-HLA monoclonal antibodies.
    Smith KD; Mace BE; Valenzuela A; Vigna JL; McCutcheon JA; Barbosa JA; Huczko E; Engelhard VH; Lutz CT
    J Immunol; 1996 Sep; 157(6):2470-8. PubMed ID: 8805647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
    Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
    Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess beta 2 microglobulin promoting functional peptide association with purified soluble class I MHC molecules.
    Kozlowski S; Takeshita T; Boehncke WH; Takahashi H; Boyd LF; Germain RN; Berzofsky JA; Margulies DH
    Nature; 1991 Jan; 349(6304):74-7. PubMed ID: 1985269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.
    Vogt AB; Stern LJ; Amshoff C; Dobberstein B; Hämmerling GJ; Kropshofer H
    J Immunol; 1995 Nov; 155(10):4757-65. PubMed ID: 7594477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.
    Martayan A; Fiscella M; Setini A; Ciccarelli G; Gambari R; Feriotto G; Beretta A; Siccardi AG; Appella E; Giacomini P
    Hum Immunol; 1997 Mar; 53(1):23-33. PubMed ID: 9127144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Invariant chain prevents the HLA-DR-restricted presentation of a cytosolic peptide.
    Long EO; LaVaute T; Pinet V; Jaraquemada D
    J Immunol; 1994 Aug; 153(4):1487-94. PubMed ID: 8046228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-induced conformational change of the class I heavy chain.
    Elliott T; Cerundolo V; Elvin J; Townsend A
    Nature; 1991 May; 351(6325):402-6. PubMed ID: 2034289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional cell surface expression by a recombinant single-chain class I major histocompatibility complex molecule with a cis-active beta 2-microglobulin domain.
    Lee L; McHugh L; Ribaudo RK; Kozlowski S; Margulies DH; Mage MG
    Eur J Immunol; 1994 Nov; 24(11):2633-9. PubMed ID: 7957555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
    Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
    J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
    Albert LJ; Ghumman B; Watts TH
    J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines.
    Anderson KS; Alexander J; Wei M; Cresswell P
    J Immunol; 1993 Oct; 151(7):3407-19. PubMed ID: 8376783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.
    Schafer PH; Green JM; Malapati S; Gu L; Pierce SK
    J Immunol; 1996 Dec; 157(12):5487-95. PubMed ID: 8955198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.